methotrexate 5mg/2ml mg/ml solution for injection
hospira uk limited - methotrexate - solution for injection - 5mg/2ml mg/ml - folic acid analogues
methotrexate intas methotrexate 50mg/2ml injection vial
accord healthcare pty ltd - methotrexate, quantity: 50 mg - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium hydroxide - antineoplastic chemotherapy - methotrexate has a broad spectrum of antineoplastic activity. it is indicated for the treatment of breast cancer, gestational choriocarcinoma, and in patients with chorioadenoma destruens and hydatidiform mole. methotrexate may be used in combination with other chemotherapeutic agents for the palliative treatment of acute leukaemias, particularly acute lymphoblastic leukaemia. it may also be used in the treatment of burkitt's lymphoma, advanced stages (iii and iv, peters' staging system) of lymphosarcoma, especially in children, and in advanced cases of mycosis fungoides. high dose therapy - in high-dose schedules, methotrexate may be effective alone or in combination therapy, in the treatment of epidermoid cancers of the head and neck, osteogenic sarcoma and bronchogenic carcinoma. calcium folinate (leucovorin calcium) must be used in conjunction with high dose methotrexate therapy. psoriasis chemotherapy (see warning box) - methotrexate may be of value in the symptomatic control of severe, recalcitrant, disabling psoriasis which is not adequately responsive to other forms of treatment. however, due to the high risk associated with its use, methotrexate should be used after the diagnosis has been definitely established, as by biopsy and/or after dermatologic consultation.
methotrexate intas methotrexate 1000mg/10ml injection vial
accord healthcare pty ltd - methotrexate, quantity: 100 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections - antineoplastic chemotherapy - methotrexate has a broad spectrum of antineoplastic activity. it is indicated for the treatment of breast cancer, gestational choriocarcinoma, and in patients with chorioadenoma destruens and hydatidiform mole. methotrexate may be used in combination with other chemotherapeutic agents for the palliative treatment of acute leukaemias, particularly acute lymphoblastic leukaemia. it may also be used in the treatment of burkitt's lymphoma, advanced stages (iii and iv, peters' staging system) of lymphosarcoma, especially in children, and in advanced cases of mycosis fungoides. high dose therapy - in high-dose schedules, methotrexate may be effective alone or in combination therapy, in the treatment of epidermoid cancers of the head and neck, osteogenic sarcoma and bronchogenic carcinoma. calcium folinate (leucovorin calcium) must be used in conjunction with high dose methotrexate therapy. psoriasis chemotherapy (see warning box) - methotrexate may be of value in the symptomatic control of severe, recalcitrant, disabling psoriasis which is not adequately responsive to other forms of treatment. however, due to the high risk associated with its use, methotrexate should be used after the diagnosis has been definitely established, as by biopsy and/or after dermatologic consultation.
methofill 7.5mg/0.15ml solution for injection pre-filled injector
accord-uk ltd - methotrexate - solution for injection - 50mg/1ml
methofill 10mg/0.2ml solution for injection pre-filled injector
accord-uk ltd - methotrexate - solution for injection - 50mg/1ml
methofill 15mg/0.3ml solution for injection pre-filled injector
accord-uk ltd - methotrexate - solution for injection - 50mg/1ml
methofill 12.5mg/0.25ml solution for injection pre-filled injector
accord-uk ltd - methotrexate - solution for injection - 50mg/1ml
methofill 17.5mg/0.35ml solution for injection pre-filled injector
accord-uk ltd - methotrexate - solution for injection - 50mg/1ml
methofill 20mg/0.4ml solution for injection pre-filled injector
accord-uk ltd - methotrexate - solution for injection - 50mg/1ml
methofill 22.5mg/0.45ml solution for injection pre-filled injector
accord-uk ltd - methotrexate - solution for injection - 50mg/1ml